It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with Medical Affairs acting as a key liaison between internal stakeholders, a new generation of physicians, and patient advocates...
Read MoreTop Stories
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Celebrating World Patient Safety Day 2024:
On World Patient Safety Day 2024, we focus on the critical...
Filter
Transforming Scientific Content with Microsoft 365 Copilot: Cactus Life Sciences in the Spotlight
We are thrilled to announce that Cactus Life Sciences has been featured in Microsoft Stories...
Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content
In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...
Readability of published vs. artificial intelligence (AI)-generated plain-language summaries (PLS)
PLS play an important role in increasing the accessibility of medical publications to a wide...
Use of audiovisual data dissemination formats (ADDFs) by medical journals: then and now
GPP 2022 guidelines endorse the use of alternative data dissemination formats, including ADDFs, to enhance...
Person-First Language (PFL) in Medical Communications: Usage and Awareness
The use of patient-first language (PFL) is an important feature of a patient-centered care model...
What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?
While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...